Skip to main content
Swedish Orphan Biovitrum AB (publ) (BIOVF)
OTCMKTS · Delayed Price · Currency is USD
30.48
+2.18 (7.70%)
At close: Jan 31, 2025

BIOVF Revenue

In the year 2024, Swedish Orphan Biovitrum AB had annual revenue of 26.03B SEK with 17.65% growth. Swedish Orphan Biovitrum AB had revenue of 7.44B in the quarter ending December 31, 2024, with 8.67% growth.

Revenue
26.03B SEK
Revenue Growth
+17.65%
P/S Ratio
n/a
Revenue / Employee
14.15M SEK
Employees
1,840
Market Cap
10.08B USD

Revenue Chart

* This company reports financials in SEK.

History

Fiscal Year End Revenue Change Growth
Dec 31, 202426.03B3.90B17.65%
Dec 31, 202322.12B3.33B17.74%
Dec 31, 202218.79B3.26B21.00%
Dec 31, 202115.53B268.00M1.76%
Dec 31, 202015.26B1.01B7.11%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Endo Inc. 1.79B
SS Innovations International 16.04M
Veradigm 1.53B
Elite Pharmaceuticals 70.00M
Glass House Brands 188.29M
Northwest Biotherapeutics 1.60M
BioStem Technologies 210.49M
SANUWAVE Health 29.30M
Revenue Rankings

Swedish Orphan Biovitrum AB News

More News